Tadeusz Robak, MD, Ph.D., is a Professor of Hematology and the Head of the Hematology Department at the Medical University and Copernicus Memorial Hospital in Lodz, Poland. He is the president of the Polish Society of Hematology and Transfusion Medicine and a member of the European School of Haematology Scientific Committee. He is the (co-)author of more than 700 scientific papers published in peer-reviewed journals. His research activities are focused mainly on chronic lymphocytic leukemia (CLL), hairy cell leukemia (HCL), and lymphoma, particularly on new protocols with purine analogs and targeted drugs. He participated in the pivotal clinical studies that influenced therapeutic standards in these diseases. Professor Robak was the principal investigator in Polish multi-center phase-3 trials, the results of which contributed to the current use of cladribine in CLL and HCL. He was the principal investigator in REACH and COMPLEMENT2 trials, key for the introduction of immunochemotherapy in relapsed/refractory CLL, and in LYM 3002 study on the use of bortezomib (VR-CAP) in the first line of mantle cell lymphoma therapy. He presented the results of his clinical research at the ASH, EHA, and EBMT meetings. He is one of the authors of the IWCLL and ESMO guidelines for CLL and ESMO guidelines for HCL. Prof. Robak is a member of the ASH, EHA, and IWCLL.
Wojciech Biernat is a Professor in Pathomorphology at the Medical University of Gdańsk, Poland. He completed his MD at the Medical University of Lodz, Poland. He serves as an editorial member and reviewer in several internationally reputed journals. He has 6252 publications with 320 citations and an h-index of 37 (Scopus, 10 November 2023).
Ewa Robak is a professor at the Department of Dermatology, Medical University of Lodz. She completed her Ph.D. studies at the Medical University of Lodz. She served as an associate professor at the Medical University of Lodz. She is a number of the Scientific Discipline Councils, at the Medical University of Lodz. She has 110 publications with 1944 citations and an h-index of 25 (Scoups, 13 November 2023).
